Status:
ACTIVE_NOT_RECRUITING
Acupressure Wristbands for GLP-1RA Related Nausea
Lead Sponsor:
Florencia Ziemke
Conditions:
Nausea
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Nausea is a common side effect of GLP-1RA medications used for treatment of Type 2 diabetes mellitus and obesity. Current recommendations for nausea relief include the use of dietary changes and presc...
Detailed Description
Nausea is the most commonly reported side effect of the class of drugs collectively known as glucagon like peptide-1 receptor agonists (GLP-1RA). GLP-1RAs are FDA approved to treat Type 2 diabetes mel...
Eligibility Criteria
Inclusion
- Adults taking GLp-1RA with nausea
Exclusion
- Adults on GLP-1RA without nausea
- Uncontrolled GERD
- Hx of Gastroparesis
- Other nausea related conditions such as vertigo
- History of chronic use of antiemetic medication for other reasons
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2025
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06939517
Start Date
February 1 2024
End Date
April 13 2025
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evexia Medical
Jupiter, Florida, United States, 33458